Top

Published in:

01-06-2020 | Care

Developing the structure of Japan’s cancer survivorship guidelines using an expert panel and modified Delphi method

Authors: Yutaka J. Matsuoka, Ryo Okubo, Yoichi Shimizu, Katsunori Tsuji, Tomomi Narisawa, Jiichiro Sasaki, Hiroyuki Sasai, Sadako Akashi-Tanaka, Tetsuya Hamaguchi, Takeshi Iwasa, Satoshi Iwata, Tomoyasu Kato, Kayo Kurotani, Dai Maruyama, Ayako Mori, Asao Ogawa, Naomi Sakurai, Taichi Shimazu, Chikako Shimizu, Takahiro Tabuchi, Miyako Takahashi, Toshimi Takano, Noriatsu Tatematsu, Yosuke Uchitomi, Chie Watanabe, Tsuguya Fukui

Published in: Journal of Cancer Survivorship | Issue 3/2020

Abstract

Purpose

To develop consensus-based components used in the first evidence-based cancer survivorship guidelines in Japan.

Methods

Purposive sampling was used to recruit a panel of experts in oncology clinical practice, nursing, health science, epidemiology, and patient advocacy. The panel engaged in a modified Delphi process to (1) generate consensus related to the definition of survivorship, (2) determine the aim and target users of the guideline, and (3) identify clinical issues for inclusion. A Web-based survey and panel meeting were conducted to obtain the panelists’ feedback on the initial draft proposed by the secretariat. Multiple online votes were then completed until all elements of the proposed guidelines reached an approval rate of 80% or higher. Following each round, iterative refinements were made based on all panelists’ feedback.

Results

Twenty-two experts were enrolled in the panel and participated in four rounds of online voting and two face-to-face meetings. Ultimately, the panel reached consensus on the definition of survivorship, the aim of the guidelines, and target users. Moreover, 11 of the original 17 clinical issues were retained. Finally, the panel selected two priority areas to implement immediately.

Conclusion

The panel’s consensus on the definition of survivorship, aim and target users of the guideline, and 11 clinical issues will serve as a compass for the development of comprehensive cancer survivorship guidelines in Japan.

Implications for Cancer Survivors

A culturally sensitive consensus approach was developed to improve the long term health and well- being of cancer survivors in Japan.

Available only for authorised users

Center for Cancer Control and Information Service NCC J. Estimates of cancer prevalence (in Japanese). 2007. https://ganjoho.jp/data/reg_stat/statistics/brochure/2007/FIG21.PDF. Accessed 9 Nov 2018.

Center for Cancer Control and Information Service NCC J. Population-based 5-year survival of cancer patients diagnosed between 2006 and 2008 in Japan (in Japanese). 2019. https://ganjoho.jp/reg_stat/statistics/stat/summary.html.

Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T, et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol. 2011;41(1):40–51. https://doi.org/10.1093/jjco/hyq167.CrossRefPubMed

Center for Cancer Control and Information Service NCC J. Trends in age-specific incidence rate (1980, 2014) (in Japanese). 2018.

Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. https://doi.org/10.1016/S0140-6736(12)60240-2.CrossRefPubMed

Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, et al. Survivorship: introduction and definition. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2014;12(1):34–45.CrossRef

Howell D, Hack TF, Oliver TK, Chulak T, Mayo S, Aubin M, et al. Survivorship services for adult cancer populations: a pan-Canadian guideline. Curr Oncol. 2011;18(6):e265–81.CrossRef

El-Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt-Chapman ML, et al. American Cancer Society colorectal cancer survivorship care guidelines. CA Cancer J Clin. 2015;65(6):428–55. https://doi.org/10.3322/caac.21286.CrossRefPubMedPubMedCentral

Cohen EE, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, et al. American Cancer Society head and neck cancer survivorship care guideline. CA Cancer J Clin. 2016;66(3):203–39. https://doi.org/10.3322/caac.21343.CrossRefPubMed

10.

Skolarus TA, Wolf AM, Erb NL, Brooks DD, Rivers BM, Underwood W 3rd, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014;64(4):225–49. https://doi.org/10.3322/caac.21234.CrossRefPubMed

11.

Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611–35. https://doi.org/10.1200/JCO.2015.64.3809.CrossRefPubMed

12.

Rubinstein EB, Miller WL, Hudson SV, Howard J, O’Malley D, Tsui J, et al. Cancer survivorship care in advanced primary care practices: a qualitative study of challenges and opportunities. JAMA Intern Med. 2017;177(12):1726–32. https://doi.org/10.1001/jamainternmed.2017.4747.CrossRefPubMedPubMedCentral

13.

Dossett LA, Hudson JN, Morris AM, Lee MC, Roetzheim RG, Fetters MD, et al. The primary care provider (PCP)-cancer specialist relationship: a systematic review and mixed-methods meta-synthesis. CA Cancer J Clin. 2017;67(2):156–69. https://doi.org/10.3322/caac.21385.CrossRefPubMed

14.

Takahashi M. Cancer survivorship: current status of research, care, and policy in Japan. Jpn J Clin Oncol. 2016;46(7):599–604. https://doi.org/10.1093/jjco/hyw057.CrossRefPubMed

15.

Okubo R, Wada S, Shimizu Y, Tsuji K, Hanai A, Imai K et al. Expectations of and recommendations for a cancer survivorship guideline in Japan: a literature review of guidelines for cancer survivorship. Japanese journal of clinical oncology. 2019. https://doi.org/10.1093/jjco/hyz070.CrossRef

16.

Tokita T. The prospects for reform of the Japanese healthcare system. Pharmacoeconomics. 2002;20(Suppl 3):55–66. https://doi.org/10.2165/00019053-200220003-00005.CrossRefPubMed

17.

Sudo K, Kobayashi J, Noda S, Fukuda Y, Takahashi K. Japan’s healthcare policy for the elderly through the concepts of self-help (Ji-jo), mutual aid (Go-jo), social solidarity care (Kyo-jo), and governmental care (Ko-jo). Biosci Trends. 2018;12(1):7–11. https://doi.org/10.5582/bst.2017.01271.CrossRefPubMed

18.

Tsutsui T, Muramatsu N, Higashino S. Changes in perceived filial obligation norms among coresident family caregivers in Japan. Gerontologist. 2014;54(5):797–807. https://doi.org/10.1093/geront/gnt093.CrossRefPubMed

19.

Kojimahara N, Nakayama T, Morizane T, Yamaguchi N, Yoshida M. Manual of Minds creating clinical practice guideline 2017 (in Japanese). 2017. https://minds.jcqhc.or.jp/s/guidance_2017_0_h. Accessed 20 Mar 2018.

20.

Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W et al. Survivorship, version 2.2017, NCCN clinical practice guidelines in oncology. Natl Compr Canc Netw 2017.

21.

Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, et al. Survivorship, version 2.2017, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2017;15(9):1140–63. https://doi.org/10.6004/jnccn.2017.0146.CrossRefPubMed

22.

NCCS. Definding cancer survivorship: living with, through, and beyond a cancer diagnosis. 2014. https://www.canceradvocacy.org/news/defining-cancer-survivorship/. Accessed 8 Aug 2018.

23.

Okubo R, Wada S, Shimizu Y, Tsuji K, Hanai A, Imai K, et al. Expectations of and recommendations for a cancer survivorship guideline in Japan: a literature review of guidelines for cancer survivorship. Jpn J Clin Oncol. 2019. https://doi.org/10.1093/jjco/hyz070.CrossRef

24.

Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008–15.PubMed

25.

Green B, Jones M, Hughes D, Williams A. Applying the Delphi technique in a study of GPs’ information requirements. Health Soc Care Community. 1999;7(3):198–205.CrossRef

26.

Institute NC. Survivorship definitions. https://cancercontrol.cancer.gov/ocs/statistics/definitions.html. Accessed 31 May 2019.

27.

NCI O. Survivorship definitions. https://cancercontrol.cancer.gov/ocs/statistics/definitions.html. Accessed 29 Oct 2019.

28.

Shapiro CL. Cancer survivorship. N Engl J Med. 2018;379(25):2438–50. https://doi.org/10.1056/NEJMra1712502.CrossRefPubMed

29.

Burke S, Wurz A, Bradshaw A, Saunders S, West MA, Brunet J. Physical activity and quality of life in cancer survivors: a meta-synthesis of qualitative research. Cancers (Basel). 2017;9(5). https://doi.org/10.3390/cancers9050053.CrossRef

30.

Fuller JT, Hartland MC, Maloney LT, Davison K. Therapeutic effects of aerobic and resistance exercises for cancer survivors: a systematic review of meta-analyses of clinical trials. Br J Sports Med. 2018;52(20):1311. https://doi.org/10.1136/bjsports-2017-098285.CrossRefPubMed

31.

Moreira ED Jr, Brock G, Glasser DB, Nicolosi A, Laumann EO, Paik A, et al. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Int J Clin Pract. 2005;59(1):6–16. https://doi.org/10.1111/j.1742-1241.2005.00382.x.CrossRefPubMed

32.

Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2005;17(1):39–57. https://doi.org/10.1038/sj.ijir.3901250.CrossRefPubMed

33.

Takahashi M, Kai I, Hisata M, Higashi Y. Attitudes and practices of breast cancer consultations regarding sexual issues: a nationwide survey of Japanese surgeons. J Clin Oncol. 2006;24(36):5763–8. https://doi.org/10.1200/JCO.2006.06.9146.CrossRefPubMed

Title: Developing the structure of Japan’s cancer survivorship guidelines using an expert panel and modified Delphi method
Authors: Yutaka J. Matsuoka
Ryo Okubo
Yoichi Shimizu
Katsunori Tsuji
Tomomi Narisawa
Jiichiro Sasaki
Hiroyuki Sasai
Sadako Akashi-Tanaka
Tetsuya Hamaguchi
Takeshi Iwasa
Satoshi Iwata
Tomoyasu Kato
Kayo Kurotani
Dai Maruyama
Ayako Mori
Asao Ogawa
Naomi Sakurai
Taichi Shimazu
Chikako Shimizu
Takahiro Tabuchi
Miyako Takahashi
Toshimi Takano
Noriatsu Tatematsu
Yosuke Uchitomi
Chie Watanabe
Tsuguya Fukui
Publication date: 01-06-2020
Publisher: Springer US
Keyword: Care
Published in: Journal of Cancer Survivorship / Issue 3/2020
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-019-00840-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 3/2020

Online social support among breast cancer patients: longitudinal changes to Facebook use following breast cancer diagnosis and transition off therapy

The impact of arm lymphedema on healthcare utilization during long-term breast cancer survivorship: a population-based cohort study

Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study

Risk factors for cancer-related distress in colorectal cancer survivors: one year post surgery

Comparison of health behaviours between cancer survivors and the general population: a cross-sectional analysis of the Lifelines cohort

The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life

Keynote webinar | Spotlight on antibody–drug conjugates in cancer